NCT02680665View on ClinicalTrials.gov

Ameparomo Capsules 250 mg Drug Use Investigation

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 19, 2015

Primary Completion Date

December 21, 2018

Study Completion Date

December 21, 2018

Conditions
Intestinal Amebiasis
Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02680665 - Ameparomo Capsules 250 mg Drug Use Investigation | Biotech Hunter | Biotech Hunter